Meet the Team

Adrian’s current research includes incentives for new drugs and vaccines to tackle Antimicrobial Resistance, the use of 'risk-sharing' arrangements between health care payers and pharmaceutical companies, including value-based pricing approaches; the economics of pharmacogenetics for health care payers and the pharmaceutical industry; economic issues that affect both R&D for and access to treatments for diseases prevalent in the developing world.

Professor Lotte Steuten is Head of Consulting and Vice President of the Office of Health Economics.

Lotte’s research interest focuses on the development and application of health economic analysis and health technology assessment (HTA), with the aim to accelerate patient access to high value health care services and treatments. She specializes in quantitative methods for estimating and comparing the expected health and economic benefits of new approaches and interventions in disease prevention, diagnostics and treatment, and prioritizing data collection to efficiently build the evidence for new interventions.

Mikel’s current research interests are the economics of the pharmaceutical industry; including innovation and incentives for encouraging medical R&D, regulation of pharmaceutical markets and social welfare analysis, and competition and incentives for health care providers.

Mehmet joined OHE in 2020 – having obtained his MSc in Health Economics from City University London in 2018. Mehmet’s main research interest is around the impact of policymaking on efficient market outcomes and subsequent effect on R&D of innovative treatments.  Mehmet is also interested in the economics of health inequalities  and has researched this area extensively as part of is MSc Dissertation.

Patricia’s main areas of research are: health-related quality of life measures, subjective well-being, cost-effectiveness thresholds, estimation of health-related outcomes, health policy evaluation, adaptation to health states, ordered choice models and theory of preferences.

Isobel joined OHE in 2020. She has an undergraduate degree in Natural Sciences specialising in infectious diseases from the University of Cambridge and a Masters of Public Health (MPH) from Imperial College London. Her MPH research focussed on inequality in pharmaceutical innovation for infectious diseases and the impact of World Bank income classification on pharmaceutical innovation. She has completed internships at the World Health Organisation and Drugs for Neglected Diseases Initiative (DNDi) in Geneva where she worked on their Paediatric HIV and Hepatitis C programmes.

Claire Green is the Personal Assistant to Chief Executive. A key aspect of her role is to provide time management and administrative support.

Nadine joined the OHE in October 2019 upon completing her MSc in Health Economics at the University of York. She conducted her dissertation research during a 3-month placement at the University of Technology Sydney; assessing whether the newly developed multi-attribute utility instrument EORTC QLU-C10D, is appropriate for use in primary brain cancer patients given the exclusion of a cognitive functioning scale.

Dimitrios’ research interests lie in the fields of the economics of innovation and specifically on the economics of pharmaceutical markets and R&D, where he applies econometric methods to examine questions related to incentives for innovation. In addition, he is interested in topics at the intersection of health and applied economics.

David's research interests broadly focus on the valuation of healthcare benefits. This includes describing health and valuing health states for the generation of quality-adjusted life years (QALYs) as well as the valuation and incorporation of broader outcomes (e.g. non-health outcomes or well-being) into the health technology assessment process.

Phill's research interests include the economics of the pharmaceutical market, the productivity and outputs of NICE, and benchmarking industry performance. He has extensive knowledge of, and experience with, data and other information used to understand the medicines market and performance of the pharmaceutical industry.

Marina’s research interests focus on the evaluation of healthcare programmes’ effectiveness, focusing on quality of life factors that impact budgets and decision making. She is also interested in the economics of health care systems in emerging markets.

Hannah joined OHE in September 2020 as an OHE Fellow after completing a MSc in Development Economics at the University of Sussex. Her dissertation focused on investigating the effect of different government responses on COVID-19 deaths. Hannah has previously obtained a BSc in Economics from the University of Exeter and is currently undertaking an MSc in Health Economics at City, University of London. She gained exposure to research and public policy through a summer internship at the Institute of Economic Affairs.

Chris has over 20 years of applied health economics experience in consulting and academia. His interests centre on the use of health economics to maximise the societal value of scarce healthcare resources, including the use of cost-effectiveness and cost-utility frameworks to evaluate value-for-money and stated preference methods to elicit patient and public values.

Bernarda’s areas of expertise include econometric modelling of health statistics at patient level and also international health statistics at country level. Prior to joining OHE in 2015, Bernarda has worked in Spanish and British academia and international organisations. She holds a PhD in Economics from the University Carlos III of Madrid and a Certificate in Quantitative Finance from Fitch Learning.